» Articles » PMID: 23023710

The Molecular Basis of T Cell Acute Lymphoblastic Leukemia

Overview
Journal J Clin Invest
Specialty General Medicine
Date 2012 Oct 2
PMID 23023710
Citations 241
Authors
Affiliations
Soon will be listed here.
Abstract

T cell acute lymphoblastic leukemias (T-ALLs) arise from the malignant transformation of hematopoietic progenitors primed toward T cell development, as result of a multistep oncogenic process involving constitutive activation of NOTCH signaling and genetic alterations in transcription factors, signaling oncogenes, and tumor suppressors. Notably, these genetic alterations define distinct molecular groups of T-ALL with specific gene expression signatures and clinicobiological features. This review summarizes recent advances in our understanding of the molecular genetics of T-ALL.

Citing Articles

Mcm5 mutation leads to silencing of Stat1-bcl2 which accelerating apoptosis of immature T lymphocytes with DNA damage.

Liu M, Li Y, Deng Z, Zhang K, Huang S, Xia J Cell Death Dis. 2025; 16(1):84.

PMID: 39929806 PMC: 11811017. DOI: 10.1038/s41419-025-07392-8.


The mitochondria as an emerging target of self-renewal in T-cell acute lymphoblastic leukemia.

Al-Hamaly M, Winter E, Blackburn J Cancer Biol Ther. 2025; 26(1):2460252.

PMID: 39905687 PMC: 11801350. DOI: 10.1080/15384047.2025.2460252.


Genetic hallmarks and clinical implications of chromothripsis in childhood T-cell acute lymphoblastic leukemia.

Pastorczak A, Urbanska Z, Styka B, Miarka-Walczyk K, Sedek L, Wypyszczak K Leukemia. 2024; 38(11):2344-2354.

PMID: 39192035 PMC: 11518979. DOI: 10.1038/s41375-024-02370-z.


Integrating rapamycin with novel PI3K/Akt/mTOR inhibitor microRNAs on NOTCH1-driven T-cell acute lymphoblastic leukemia (T-ALL).

Arjmand F, Shojaei S, Khalili M, Dinmohammadi H, Poopak B, Mohammadi-Yeganeh S Bioimpacts. 2024; 14(4):28870.

PMID: 39104620 PMC: 11298021. DOI: 10.34172/bi.2023.28870.


Oncogenic dependency on SWI/SNF chromatin remodeling factors in T-cell acute lymphoblastic leukemia.

Kim H, Tan T, Lee D, Huang X, Ong J, Kelliher M Leukemia. 2024; 38(9):1906-1917.

PMID: 38969731 DOI: 10.1038/s41375-024-02331-6.


References
1.
Wakabayashi Y, Watanabe H, Inoue J, Takeda N, Sakata J, Mishima Y . Bcl11b is required for differentiation and survival of alphabeta T lymphocytes. Nat Immunol. 2003; 4(6):533-9. DOI: 10.1038/ni927. View

2.
Asnafi V, Buzyn A, Le Noir S, Baleydier F, Simon A, Beldjord K . NOTCH1/FBXW7 mutation identifies a large subgroup with favorable outcome in adult T-cell acute lymphoblastic leukemia (T-ALL): a Group for Research on Adult Acute Lymphoblastic Leukemia (GRAALL) study. Blood. 2008; 113(17):3918-24. DOI: 10.1182/blood-2008-10-184069. View

3.
Clappier E, Collette S, Grardel N, Girard S, Suarez L, Brunie G . NOTCH1 and FBXW7 mutations have a favorable impact on early response to treatment, but not on outcome, in children with T-cell acute lymphoblastic leukemia (T-ALL) treated on EORTC trials 58881 and 58951. Leukemia. 2010; 24(12):2023-31. DOI: 10.1038/leu.2010.205. View

4.
Clappier E, Cuccuini W, Kalota A, Crinquette A, Cayuela J, Dik W . The C-MYB locus is involved in chromosomal translocation and genomic duplications in human T-cell acute leukemia (T-ALL), the translocation defining a new T-ALL subtype in very young children. Blood. 2007; 110(4):1251-61. DOI: 10.1182/blood-2006-12-064683. View

5.
Van Limbergen H, Beverloo H, van Drunen E, Janssens A, Hahlen K, Poppe B . Molecular cytogenetic and clinical findings in ETV6/ABL1-positive leukemia. Genes Chromosomes Cancer. 2001; 30(3):274-82. View